SHREYASKUMAR R. PATEL
Impact in
- Gastroenterology top 0.05%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.05%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Sarcoma Diagnosis and Treatment 142
- Gastric Cancer Management and Outcomes 8
-
- Gastrointestinal Tumor Research and Treatment 38
- Co-authors
- Robert S. Benjamin (93 shared papers)Peter W. T. Pisters (37 shared papers)Raphael E. Pollock (32 shared papers)Matthew T. Ballo (22 shared papers)Gunar K. Zagars (21 shared papers)Robert G. Maki (16 shared papers)Lei L. Chen (7 shared papers)Haesun Choi (5 shared papers)
- Journals
- Cancer (44 papers)Journal of Clinical Oncology (21 papers)Annals of Oncology (10 papers)Current Oncology Reports (10 papers)International Journal of Radiation Oncology*Biology*Physics (8 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
SHREYASKUMAR R. PATEL
228 papers receiving 14.9k citations
SHREYASKUMAR R. PATEL's Hit Papers
Peers
Comparison fields: 5 of 110
- Gastroenterology 2.6k
- Pulmonary and Respiratory Medicine 9.1k
- Rheumatology 2.6k
- Oncology 4.1k
- Pathology and Forensic Medicine 1.6k
Countries citing papers authored by SHREYASKUMAR R. PATEL
This map shows the geographic impact of SHREYASKUMAR R. PATEL's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SHREYASKUMAR R. PATEL with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SHREYASKUMAR R. PATEL more than expected).
Fields of papers citing papers by SHREYASKUMAR R. PATEL
This network shows the impact of papers produced by SHREYASKUMAR R. PATEL. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SHREYASKUMAR R. PATEL. The network helps show where SHREYASKUMAR R. PATEL may publish in the future.
Co-authors
The 25 scholars most cited alongside SHREYASKUMAR R. PATEL, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 236 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria Hit paper breakdown → | 2007 | 1190 |
| 2 | Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2009 | 1050 |
| 3 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Hit paper breakdown → | 2015 | 631 |
| 4 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2016 | 582 |
| 5 | Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Hit paper breakdown → | 2007 | 580 |
| 6 | Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy Hit paper breakdown → | 2003 | 551 |
| 7 | We Should Desist Using RECIST, at Least in GIST Hit paper breakdown → | 2007 | 456 |
| 8 | 2001 | 316 | |
| 9 | 2010 | 314 | |
| 10 | 2011 | 266 | |
| 11 | 2014 | 230 | |
| 12 | 2007 | 214 | |
| 13 | 2001 | 212 | |
| 14 | 2006 | 212 | |
| 15 | 1997 | 205 | |
| 16 | 2009 | 204 | |
| 17 | 2011 | 190 | |
| 18 | 1993 | 190 | |
| 19 | 2010 | 178 | |
| 20 | 2002 | 177 |
About SHREYASKUMAR R. PATEL
SHREYASKUMAR R. PATEL is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Oncology, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 236 papers that have together received 15.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (142 papers), Gastrointestinal Tumor Research and Treatment (38 papers), Vascular Tumors and Angiosarcomas (25 papers), Cardiac tumors and thrombi (24 papers), Bone Tumor Diagnosis and Treatments (20 papers), Management of metastatic bone disease (11 papers), Soft tissue tumor case studies (8 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Gastroenterology (2.6k citations), Pulmonary and Respiratory Medicine (9.1k citations), Rheumatology (2.6k citations), Oncology (4.1k citations) and Pathology and Forensic Medicine (1.6k citations). SHREYASKUMAR R. PATEL has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Robert S. Benjamin, Peter W. T. Pisters, Raphael E. Pollock, Matthew T. Ballo, Gunar K. Zagars, Robert G. Maki, Lei L. Chen, Haesun Choi, Homer A. Macapinlac and Barry W. Feig. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Annals of Oncology, Current Oncology Reports and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.